Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3985269 | 1.00 | ALDH1A1 (0.33) | ALDH1A1KDM4EMAPTSMN1; SMN2DNM1 | |
| SCHEMBL329406 | 0.87 | ALDH1A1 (0.39) | ALDH1A1KDM4ESMN1; SMN2DNM1TSHR | |
| Hydrochloric Acid SCHEMBL20741376 | 0.85 | DNM1 (0.41) | ALDH1A1KDM4ESMN1; SMN2DNM1TSHR | |
| SCHEMBL4751094 | 0.84 | MAPT (0.34) | ALDH1A1MAPTTSHR | |
| SCHEMBL3987973 | 0.84 | MAPT (0.34) | ALDH1A1MAPTTSHR | |
| SCHEMBL28494001 | 0.83 | ALDH1A1 (0.33) | ALDH1A1KDM4ESMN1; SMN2DNM1TSHR | |
| SCHEMBL27749900 | 0.81 | TSHR (0.41) | ALDH1A1MAPTSMN1; SMN2TSHR | |
| SCHEMBL379968 | 0.81 | ALDH1A1 (0.43) | ALDH1A1KDM4ESMN1; SMN2DNM1TSHR | |
| SCHEMBL25197547 | 0.79 | DNM1 (0.33) | ALDH1A1KDM4ESMN1; SMN2DNM1TSHR | |
| SCHEMBL16225035 | 0.79 | DNM1 (0.33) | ALDH1A1KDM4ESMN1; SMN2DNM1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008149375-A1 | IMPROVED ORGANOSILICON COMPOUNDS | RANKA, SEEMA, AJAY (IN) | 2008-12-11 | — | — | WO | claimed |
| US-20080009644-A1 | Organosilicon Compounds | ZYDEX INDUSTRIES | 2008-01-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080009644-A1 | Organosilicon Compounds | CUL1, CUL3, MGAM | ALDH1A1 1076/4885KDM4E 2377/4885MAPT 2267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.